Legend Biotech(LEGN) - 2024 Q4 - Annual Report

EXHIBIT 99.1 Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights SOMERSET, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported financial results for the fourth quarter and year ended December 31, 2024, and key corporate highlights. "We are coming off a tremendously successful year. Our 2024 total revenue nearly achieved blockbuster status, and we are just now building out our m ...